- Issuer ticker
-
IMNM
- Reported as of
-
10 Jun 2026
- Net transaction value
-
$0
- SEC form
-
4
- Accepted by SEC
-
12 Jun 2026, 17:54:12 UTC
Filing notes and source
Key filing fact
Jean Jacques Bienaime filed Form 4 for Immunome Inc. (IMNM) on 12 Jun 2026.
Key facts
- This page summarizes Jean Jacques Bienaime's Form 4 filing for Immunome Inc. (IMNM).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 12 Jun 2026, 17:54.
Change
- Previous filing in this sequence was filed on 10 Jun 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001221590
Primary reporting owner
BIENAIME JEAN JACQUES
- Relationship
-
Director
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IMNM
transaction
Derivative
Director Stock Option (right to buy)
Award
- Transaction value
- Shares
- +9,897
- Change %
- Price
-
$0.000000*
- Shares after
- 9,897
- Date
- 10 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,897
- Exercise price
- $18.16
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote